AT297219B - Verfahren zur Herstellung eines Staupeimpfstoffes - Google Patents

Verfahren zur Herstellung eines Staupeimpfstoffes

Info

Publication number
AT297219B
AT297219B AT809769A AT809769A AT297219B AT 297219 B AT297219 B AT 297219B AT 809769 A AT809769 A AT 809769A AT 809769 A AT809769 A AT 809769A AT 297219 B AT297219 B AT 297219B
Authority
AT
Austria
Prior art keywords
preparation
distemper vaccine
distemper
vaccine
Prior art date
Application number
AT809769A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT297219B publication Critical patent/AT297219B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT809769A 1968-08-23 1969-08-22 Verfahren zur Herstellung eines Staupeimpfstoffes AT297219B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1792356A DE1792356C2 (de) 1968-08-23 1968-08-23 Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
AT297219B true AT297219B (de) 1972-03-10

Family

ID=5707386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT809769A AT297219B (de) 1968-08-23 1969-08-22 Verfahren zur Herstellung eines Staupeimpfstoffes

Country Status (5)

Country Link
AT (1) AT297219B (fr)
BE (1) BE737945A (fr)
DE (1) DE1792356C2 (fr)
FR (1) FR2016289A1 (fr)
NL (1) NL6912389A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029018A1 (fr) * 1998-11-12 2000-05-25 Changchun Institute Of Biological Products Ministry Of Public Health Vaccin combine contre l'hepatite a et la rougeole et son procede de preparation
CN1062770C (zh) * 1998-11-12 2001-03-07 卫生部长春生物制品研究所 甲肝-麻疹二联疫苗及其生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634903A (fr) *
US3143474A (en) * 1962-07-30 1964-08-04 Sterling Drug Inc Preparation of duck-embryo modified infectious canine hepatitis virus vaccine
AT248791B (de) * 1963-03-07 1966-08-10 Philips Electronic Pharma Verfahren zum Schützen von Hunden vor Staupe
US3285817A (en) * 1965-08-17 1966-11-15 Philips Roxane Method of protecting dogs at birth against canine distemper

Also Published As

Publication number Publication date
DE1792356C2 (de) 1983-03-03
DE1792356A1 (de) 1971-11-18
NL6912389A (fr) 1970-02-25
BE737945A (fr) 1970-02-25
FR2016289A1 (en) 1970-05-08

Similar Documents

Publication Publication Date Title
AT307737B (de) Verfahren zur Herstellung eines modifizierten Organopolysiloxans
CH538473A (de) Verfahren zur Herstellung eines 1-substituierten 3-Phenoxypyrrolidins
AT294544B (de) Verfahren zur Herstellung eines Milchsäure enthaltenden Brotaufstrichs
CH513786A (de) Verfahren zur Herstellung von Styrylnaphthalin-Derivaten
AT318548B (de) Verfahren zur Herstellung eines Deshydratisierkatalysators
CH520103A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH524609A (de) Verfahren zur Herstellung von 14-Hydroxynormorphinonderivaten
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
AT297219B (de) Verfahren zur Herstellung eines Staupeimpfstoffes
AT305124B (de) Verfahren zur Herstellung eines Mittels zur Aromatisierung
CH519458A (de) Verfahren zur Herstellung von Isoprenoidchinonderivaten
CH509333A (de) Verfahren zur Herstellung eines Gemisches von Triazinyl-aminostilbenderivaten
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
CH542178A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
CH513863A (de) Verfahren zur Herstellung von Benzomorphanderivaten
CH518956A (de) Verfahren zur Herstellung von Isochinuclidin-Derivaten
CH535281A (de) Verfahren zur Herstellung eines nichtanaphylaktischen PPAO-Vakzins
AT286497B (de) Verfahren zur Herstellung einer Vaccine
CH521949A (de) Verfahren zur Herstellung von Formamido-cycloalkanderivaten
CH517112A (de) Verfahren zur Herstellung von N-Glykoluril-Derivaten
CH520161A (de) Verfahren zur Herstellung von 5-Nitrofuranderivaten
CH510682A (de) Verfahren zur Herstellung von Dihalogentriazinderivaten
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
AT300759B (de) Verfahren zur Herstellung von Dihydroxyarylsulfoniumsalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee